On a different front, here's a particularly interesting article well worth the read:
How the COVID-19 Pandemic Could End
Recent epidemics provide clues to ways the current crisis could stopwww.scientificamerican.com
And this is pretty darned good news if it pans out...which is looking quite hopeful.
University of Oxford Covid-19 vaccine: everything we know so far
A million doses of their experimental coronavirus vaccine could be ready as early as September, Oxford scientists saywww.telegraph.co.uk
And this is just starting to break right now. Not a cure, but a treatment which could be a very positive situation as well:
Take that with a grain of salt. Gilead is a relatively new company that was cash rich from its blockbuster hepatitis C drug that it sold for $1000 a pill (massive controversy over this a while back) but a competitor came out and severely undercut the price and knocked the company down a peg or three. Gilead needs this exposure to bolster its share price. The news spin is the bolstering you see.